Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Ann Med Health Sci Res ; 4(4): 634-7, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25221719

ABSTRACT

BACKGROUND: Since there is no disease-specific instrument for measuring quality-of-life (QOL) in Ostomy patients in Persian language. AIM: This study was designed to translate and evaluate the validity and reliability of City of Hope-quality of life-Ostomy questionnaire (COH-QOL-Ostomy questionnaire). SUBJECTS AND METHODS: This study was designed as cross-sectional study. Reliability of the subscales and the summary scores were demonstrated by intra-class correlation coefficients. Pearson's correlations of an item with its own scale and other scales were calculated to evaluated convergent and discriminant validity. Clinical validity was also evaluated by known-group comparisons. RESULTS: Cronbach's alpha coefficient for all subscales was about 0.70 or higher. Results of interscale correlation were satisfactory and each subscale only measured a single and specified trait. All subscales met the standards of convergent and discriminant validity. Known group comparison analysis showed significant differences in social and spiritual well-being. CONCLUSION: The findings confirmed the reliability and validity of Persian version of COH-QOL-Ostomy questionnaire. The instrument was also well received by the Iranian patients. It can be considered as a valuable instrument to assess the different aspects of health related quality-of-life in Ostomy patients and used in clinical research in the future.

2.
Colorectal Dis ; 13(6): 697-702, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20184633

ABSTRACT

AIM: This study quantified prospectively the amount of rectal wall removed during stapled haemorrhoidopexy and assessed its effect on ano-rectal function and health-related quality of life. METHOD: Thirty-three consecutive patients who underwent stapled haemorrhoidopexy for second- or third- degree haemorrhoids, or for failed medical treatment, in the Department of Surgery and Gastroenterological Sciences at the University of Padova were included. All patients were assessed preoperatively and postoperatively using a structured questionnaire to determine the number of defecations per week, incomplete defecations, time taken to defecate any difficulty in defecating, soiling, the use of drugs and continence. All patients were reassessed at 1 and 2 weeks and at 30 days after the procedure using the Cleveland Global Quality of Life (CGQL) questionnaire. All patients underwent preoperative and postoperative ano-rectal manometry at least 30 days after stapled haemorrhoidopexy. RESULTS: The median surface area of the resected rectal wall was 10.5 (range, 9-15) mm(2) and the median thickness was 3 (range, 2-4) mm. Muscle tissue was included in all specimens. The median thickness of the resected rectal wall correlated inversely with the rectal volume when the recto-anal inhibitory reflex (RAIR) was initiated during postoperative manometry (ρ = -0.50, P = 0.07). A significant, direct correlation was found between the surface area of the resected rectal wall and the rectal volume during postoperative manometry (ρ = 0.53, P = 0.08) and the use of analgesic drugs after 2 weeks (ρ = 0.63, P = 0.04). Significant correlations were found between being female and postoperative resting pressure (ρ = -0.74, P < 0.01), squeeze pressure (ρ = -0.64, P = 0.01) and maximum tolerated volume (ρ = -0.78, P < 0.01). CONCLUSION: Stapled haemorrhoidopexy is safe and effective. The thicker the resected rectal wall, the lower the volume of initiation of the RAIR.


Subject(s)
Hemorrhoids/surgery , Rectum/pathology , Rectum/surgery , Surgical Stapling , Adult , Anal Canal/physiopathology , Defecation , Digestive System Surgical Procedures/methods , Female , Humans , Male , Manometry , Middle Aged , Pain, Postoperative , Patient Satisfaction , Postoperative Period , Prospective Studies , Quality of Life , Recovery of Function , Rectum/physiopathology , Time Factors
3.
Minerva Chir ; 59(4): 317-24, 2004 Aug.
Article in English, Italian | MEDLINE | ID: mdl-15278026

ABSTRACT

AIM: In this study we evaluated the possibility of performing a cross small bowel transplantation (CrSBTx) in which, at the same time, 2 pigs were both donors and later recipients of intestinal grafts. The hemodynamic and metabolic impact of this original transplantation model on the animals was determined. METHODS: Ten large White adult female pigs underwent a 2 stage procedure. The principal intraoperative hemodynamic and metabolic parameters were measured at different times during the operation. In the 3 days that followed the operation, renal function, liver and pancreatic damage were investigated. RESULTS: Our surgical model permits us to keep excellent hemodynamic and metabolic stability with low mortality. CONCLUSION: The need of half of animals with respect to conventional models represents an ethical and economic advantage of CrSBTx and we propose it for intestinal transplant studies in large animals.


Subject(s)
Intestine, Small/transplantation , Animals , Data Interpretation, Statistical , Female , Follow-Up Studies , Hemodynamics , Monitoring, Intraoperative , Swine , Time Factors , Tissue Donors
5.
Cell Transplant ; 5(1): 53-5, 1996.
Article in English | MEDLINE | ID: mdl-8665077

ABSTRACT

We have tested the effect of donor bone marrow cell (DBMC) infusion on the survival of pancreatic islet allografts in the rat, without the use of cytoablative recipient conditioning. Lewis and diabetic Brown Norway rats were used as donors and recipients, respectively. Donor islets were placed beneath the left renal capsule. Infusion of DBMC and temporary immunosuppression followed by delayed islet transplantation resulted in indefinite survival of all islet grafts (MST > 180 days). Control animals demonstrated recurrent hyperglycemia (islet allografts rejection). Donor bone marrow derived cells were detected in the spleen and cervical lymph nodes of BN recipients of LEW bone marrow but not in the recipients of islet transplants alone. Second set full thickness skin grafts were performed in normal BN and in recipients of a previously successful ITX. Donor specific skin grafts were accepted in the animals that had received DBMC 40 days before the islet allograft, while animals receiving DBMC at the time of the islet allograft rejected the donor specific skin graft similarly to the controls. However, these animals did not reject a second set donor-specific islet transplant. The results indicate that radiation conditioning of the recipients was not necessary to induce microchimerism and graft acceptance in this rodent model of islet allotransplantation.


Subject(s)
Bone Marrow Transplantation/immunology , Diabetes Mellitus, Experimental/surgery , Graft Survival/immunology , Immunosuppression Therapy/methods , Islets of Langerhans Transplantation/immunology , Animals , Bone Marrow Cells , Bone Marrow Transplantation/methods , Graft Rejection/immunology , Rats , Rats, Inbred BN , Rats, Inbred Lew , Skin Transplantation/immunology , Time Factors , Transplantation, Homologous
14.
J Surg Oncol ; 57(1): 11-6, 1994 Sep.
Article in English | MEDLINE | ID: mdl-8065144

ABSTRACT

The effects of the cholecystokinin (CCK)-analogue, caerulein, and CCK-receptor antagonist lorglumide (CR-1409) on pancreatic carcinogenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA) were studied. One hundred thirty rats were divided into the following 10 treatment groups: group 1, DMBA (2-3 mg); group 2, DMBA + caerulein (5 micrograms/kg); group 3, DMBA + caerulein + CR-1409 (12 mg/kg); group 4, caerulein + DMBA; group 5, caerulein + CR-1409 + DMBA; group 6, DMBA + CR-1409; group 7, CR-1409 + DMBA; group 8, caerulein; group 9, CR-1409; and group 10, sham operation + saline. DMBA was surgically implanted into the pancreas. Caerulein and/or CR-1409 was administered twice daily for 15 days after (in groups 2, 3, and 6) or before (in groups 4, 5, and 7) DMBA implantation. Six months after carcinogen administration, all rats were sacrificed and autopsied. The incidence of pancreatic cancer appeared significantly (P < 0.001) increased when caerulein was administered following DMBA implantation. CR-1409 significantly inhibited (P < 0.02) caerulein effects and reduced tumor growth when injected after carcinogen exposure.


Subject(s)
Adenocarcinoma/prevention & control , Ceruletide/pharmacology , Pancreas/drug effects , Pancreatic Neoplasms/prevention & control , Proglumide/analogs & derivatives , Receptors, Cholecystokinin/antagonists & inhibitors , 9,10-Dimethyl-1,2-benzanthracene , Adenocarcinoma/chemically induced , Adenocarcinoma/pathology , Animals , Body Weight/drug effects , Chi-Square Distribution , DNA, Neoplasm/drug effects , Male , Organ Size/drug effects , Pancreas/pathology , Pancreatic Neoplasms/chemically induced , Pancreatic Neoplasms/pathology , Proglumide/pharmacology , Random Allocation , Rats
15.
Nature ; 371(6495): 351-5, 1994 Sep 22.
Article in English | MEDLINE | ID: mdl-8090207

ABSTRACT

Insulin-dependent diabetes mellitus (IDDM) is a T-cell-mediated autoimmune disease whose onset is believed to be triggered by unknown environmental factors acting on a predisposing genetic background. Islet-infiltrating T (IIT) cells from two IDDM patients, who had died at the onset of the disease from brain swelling as a complication of ketoacidosis, were analysed. The results provided evidence for the involvement of a pancreatic islet cell membrane-bound superantigen as a diabetes aetiopathogenetic factor. There was a selective expansion of a T-cell receptor (TCR) variable segment of the beta-chain (V beta 7) in these IIT cells in association with unselected V alpha-chain segments; extensive junctional diversity of the TCR V beta 7 chains; and evidence of positive selection, after exposure to diabetic islet cell membrane preparations, of V beta 7+ T-cell clones among peripheral blood lymphocytes from non-diabetic individuals.


Subject(s)
Autoantigens/immunology , Diabetes Mellitus, Type 1/immunology , Islets of Langerhans/immunology , Superantigens/immunology , T-Lymphocytes/immunology , Amino Acid Sequence , Antigens, CD/immunology , Autoradiography , Cell Differentiation , Cell Membrane/immunology , Child , Clone Cells , Flow Cytometry , Humans , Immunoenzyme Techniques , Islets of Langerhans/cytology , Male , Molecular Sequence Data , Receptors, Antigen, T-Cell, alpha-beta/biosynthesis , Receptors, Antigen, T-Cell, alpha-beta/genetics , Spleen/cytology , Spleen/immunology
18.
J Surg Oncol ; 52(3): 137-41, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8441267

ABSTRACT

Serial serum CA 19-9 assays were performed in 30 consecutive patients who underwent resection for pancreatic cancer. Patients with preoperative CA 19-9 levels < 200 U/ml had significantly better prognosis than those with CA 19-9 > 200 U/ml (P < 0.001). Serum tumor marker normalized in 14 patients after tumor resection, and survival in this group was significantly higher than that of patients with persistently elevated CA 19-9 (P < 0.0001). Prognosis was also influenced by absence of lymph node metastases (P < 0.02) and radicality of resection (P < 0.005). Elevation of serum CA 19-9 levels after operation well predicted tumor recurrence from 1-10 months before clinical and radiological evidence. CA 19-9 determination is useful as a prognostic index after resection for pancreatic carcinoma and as a surveillance test in monitoring the efficacy of treatment.


Subject(s)
Antigens, Tumor-Associated, Carbohydrate/blood , Pancreatic Neoplasms/immunology , Pancreatic Neoplasms/surgery , Actuarial Analysis , Adult , Aged , Chi-Square Distribution , Female , Humans , Lymphatic Metastasis , Male , Middle Aged , Pancreatectomy , Prognosis , Recurrence , Regression Analysis , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...